GI and HPB surgeon. MBBS MS DNB(SGE) Interests: Medicine, History, Marathi, Languages, Cricket. P̶o̶l̶i̶t̶i̶c̶s̶ Retweet≠endorsement. संस्कृतविद्यार्थी.
Miraj
Joined August 2010
- Tweets55.3K
- Following2.2K
- Followers3.4K
- Likes72.5K
Pinned Tweet
I tweet primarily in English and Marathi, and occasionally in other languages.
Topics: Surgery, MedEd, Cricket, Trivia, Marathi, Linguistics, Miraj town and its vicinity.
A few of notable tweets:
teapaw.org/search?q=from%3Apathak…
माझे मराठीतील ठळक ट्विट्स: teapaw.org/search?q=from%3Apathak… – at Sangli-Miraj Kupwad, India
Sudhanwa Pathak MBBS retweeted
Tukaram ji should also suspend the licences of restaurants that dilute their liquid handwash with water.
Sudhanwa Pathak MBBS retweeted
Air Chief Marshal Amar Preet Singh, PVSM, AVSM bids farewell to the uniform today after 42 years of commissioned service and four years of training.
Under his stewardship, IAF brought laurels to the Nation during Operation SINDOOR.
You did a great job, Chief 👍👏
As they say, A soldier never retires. Safe landings always
Jai Hind 🇮🇳
@IAF_MCC
PC: As marked
Sudhanwa Pathak MBBS retweeted
In your personal opinion, which is India's all-round best and worst city or town:
Best:
Worst:
Sudhanwa Pathak MBBS retweeted
Another Opportunity to Verify Your Name in Maharashtra’s Electoral Roll!
Deadline Extended to 13 November 2026!
The Election Commission of India has once again extended the deadline for filing claims and objections under the Special Intensive Revision (SIR) of electoral rolls in Maharashtra. This gives eligible citizens additional time to get their names included, correct errors, or raise objections.
📌 Revised Schedule:
✅ Filing of claims and objections: 31 August – 13 November 2026
✅ Disposal of claims and objections: By 25 November 2026
✅ Publication of the final electoral roll: 30 November 2026
Urging all citizens to carefully verify their names and details in the draft electoral roll. Ensure that applications for new registrations, corrections to existing entries or objections, wherever applicable, are submitted no later than 13 November 2026.
This extended opportunity offers every eligible citizen the chance to secure their right to vote and ensure that the electoral rolls remain accurate, complete and up to date. An accurate electoral roll is the foundation of a strong democracy. Every citizen’s active participation strengthens the integrity of our democratic process.
मतदार यादीतील नाव व तपशील तपासण्याची पुन्हा एक संधी!
दावे-हरकतींसाठी 13 नोव्हेंबरपर्यंत मुदतवाढ!
महाराष्ट्रातील मतदार यादीच्या विशेष सखोल पुनरीक्षण (SIR) कार्यक्रमांतर्गत प्रारूप मतदार यादीवरील दावे व हरकती दाखल करण्यासाठी भारत निवडणूक आयोगाने पुन्हा एकदा मुदतवाढ दिली आहे. यामुळे पात्र नागरिकांना आपले नाव मतदार यादीत समाविष्ट करून घेण्याची, नोंदींमधील त्रुटी दुरुस्त करण्याची आणि आवश्यकतेनुसार हरकती नोंदवण्याची आणखी एक संधी मिळाली आहे.
📌 सुधारित वेळापत्रक:
✅ दावे व हरकती दाखल करण्याचा कालावधी : 31 ऑगस्ट ते 13 नोव्हेंबर 2026
✅ दावे व हरकती निकाली काढण्याची प्रक्रिया : 25 नोव्हेंबर 2026
✅ अंतिम मतदार यादीचे प्रकाशन : 30 नोव्हेंबर 2026
प्रारूप मतदार यादीत आपले नाव आणि तपशील तपासा. नाव समाविष्ट करायचे असल्यास, नोंदींमध्ये दुरुस्ती करायची असल्यास किंवा आवश्यकतेनुसार हरकत नोंदवायची असल्यास 13 नोव्हेंबर 2026 पूर्वी संबंधित अर्ज दाखल करा.
नागरिकांनो, मिळालेल्या या अतिरिक्त संधीचा अवश्य लाभ घ्या! प्रत्येक पात्र नागरिकाचा मतदानाचा हक्क सुरक्षित राहणे आणि मतदार यादी अचूक व अद्ययावत असणे हे सशक्त लोकशाहीसाठी महत्त्वाचे आहे. लोकशाही अधिक सक्षम करण्याच्या या प्रक्रियेत आपला सहभाग नोंदवा!
#Maharashtra #SIR #ElectionCommission
Sudhanwa Pathak MBBS retweeted
My grandfather was recently interviewed for a blog by one of his former patients after his assisted pull up machine exercise video went viral ,
At the age of 94 (turning 95 soon) , he strength trains almost everyday, attends OPD, conducts educational seminars/ webinars and attends conferences we decided to record a few of his answers.
First question - what is the secret to your fitness?
Sudhanwa Pathak MBBS retweeted
IMPORTANT: World Bank Poverty and Equity Report October 2026: India has recorded one of the fastest poverty reductions in the world between 2011 and 2023, lifting an estimated 496 million people out of poverty.
Extreme Poverty ($3.00/day, 2021 PPP): The share of the population living in extreme poverty dropped sharply from 27.1% to 2.6%.
Sudhanwa Pathak MBBS retweeted
I recently learned about the staggering gap in surgical pricing across Mumbai:
100-bed suburban hospital: ₹1.3 lakh
Corporate hospital (e.g., Hinduja): ₹6.5 lakh for laparoscopic Hysterectomy ( Packages by Insurance company )
Ayushman Bharat scheme: ~₹50,000
Same surgery, identical clinical procedure—a 5x ro 10x price difference.
Why are insurance companies willing to clear inflated corporate bills worth ₹6.5 lakh without hesitation, but aggressively scrutinize and delay a genuine ₹1 lakh claim from a smaller nursing home?
The end victim is the regular consumer. Massive payouts to corporate hospitals drive up overall claim expenditure, which insurance companies directly pass on to you through surging annual premiums.
If mid-sized hospitals are squeezed out, corporate monopolies will be the only option left. Corporate hospitals certainly deserve a premium for infrastructure, but unchecked billing requires regulatory limits.
Sudhanwa Pathak MBBS retweeted
Democratising access to breast-health information🙏
Having launched NARI (National Awareness & Resource Initiative for Breast Health) a few months ago, which is an AI-enabled digital avatar - the Ushalakshmi Breast Cancer Foundation has now developed a text-based conversational version for those who prefer typing their questions rather than interacting with the avatar.
It provides conversational, AI-enabled information on breast health, benign breast conditions and breast cancer.
🌍 Anytime… Anyone… Anywhere…
Ask NARI questions in English, Hindi, Telugu, Tamil, Kannada, Malayalam, Marathi, Gujarati, Punjabi, Bengali, Odia, Assamese and many other spoken languages from around the world.
🔗 Explore TEXT BASED NARI
nari.asika.ai/
@narendramodi
#empoweringpeople
#impactinglives
#artificialintelligence
Sudhanwa Pathak MBBS retweeted
Looking for a last minute Deepavali gift? Try this bangle and jewellery pouch from @SamvitSudha, the not-for-profit women empowerment initiative of Shri Chitrapur Math. This is not a paid endorsement. I am proud to be their brand ambassador for the last several years!
Sudhanwa Pathak MBBS retweeted
एमपीएससी परीक्षांबाबतची निवेदने १६ नोव्हेंबरपर्यंत चौकशी आयोगाकडे पाठविण्याचे आवाहन चौकशी आयोगाचे सदस्य सचिव तुकाराम मुंढे यांनी केले आहे.
या प्रकरणांशी संबंधित माहिती असलेले परीक्षार्थी किंवा विद्यार्थी व अन्य व्यक्तींनी तसेच संबंधित नोंदणीकृत संस्थांनी आपल्या निवेदनाची व कागदपत्रांची एक प्रत [email protected] या ई-मेलवरही पाठविण्याचे आवाहन त्यांनी केले आहे.
तक्रारी दाखल करण्यासंदर्भात आवश्यक माहिती किंवा मदतीकरीता चौकशी आयोग कार्यालयाचा 022-20867677 हा दूरध्वनी क्रमांक उपलब्ध करुन देण्यात आला आहे.
@Tukaram_IndIAS
#MPSC
Sudhanwa Pathak MBBS retweeted
दिव्य दीपोत्सव की प्रतीक्षा में सजी भव्य राम नगरी
दीपावली के पावन पर्व पर अपने आराध्य प्रभु श्रीराम के स्वागत में संपूर्ण श्रीराम जन्मभूमि परिसर अलौकिक आभा से दमक रहा है। आधुनिक रोशनी से जगमगाते भव्य मंदिर की छटा मन मोह लेने वाली है। आइए, इस पावन बेला पर श्रद्धा का एक दीप आप भी प्रज्वलित करें।
फोटो - श्रीराम जन्मभूमि तीर्थ क्षेत्र ट्रस्ट, अयोध्या
Sudhanwa Pathak MBBS retweeted
10.5% of the Indian population or around 150 million people, are above the age of 60.
And this number is increasing, as over 19,500 Indians turn 60 each day.
Of these, around 24% struggle with at least one daily activity
48% with things like shopping and handling money
Over half of those above 65 suffer from chronic illness
A fourth of them have comorbidities.
In response, the senior-care sector is expanding too—albeit not fast enough.
the-ken.com/story/india-need… @Coffeehudigi
Sudhanwa Pathak MBBS retweeted
Experience Endoscopy @ AIG Live 2026
Endoscopy meets storytelling for the very first time!
We are breaking traditional communications to bring you real clinical scenarios through a first-of-its-kind visual comic series.
First, we dive into the complexities of EUS-Guided Gastroenterostomy, a game-changing, minimally invasive alternative for complex GI cases that redefines what’s possible in therapeutic endoscopy.
At AIG LIVE 2026, go beyond the textbook and watch global masters perform live, real-time interventions.
Gain practical insights you can directly apply in your own endoscopy practice.
4–5 December 2026 | HITEX, Hyderabad
Don't just watch endoscopy evolve. Evolve with it!
Register now: event.aigacademics.com/
@gvraoaig @DrLakhtakia @RupTaluk @ZaheerNabi8 @AnandVKulkarni2 @drmohanjr @miNitinjagtap
@RakeshKalapala1 @drhrr @drgouthamreddy @DrSonamMathur @DrAnudeepKV1 @DrRupaBanerjee1 @drmithunsharma @manasa_alla @AnandVKulkarni2 @drjahangeer09
#AIGLIVE2026 #AIGHospitals #Endoscopy #Gastroenterology #TherapeuticEUS #EUSGastroenterostomy #MedicalInnovation #MedicalComics #GIMedicine #Hyderabad
Sudhanwa Pathak MBBS retweeted
Absolute DISASTER at Sion Bridge!
The new Sion Station Traffic Signal and the existing Sion Circle Signal (~50m apart) are in different phases leading to traffic backing up all the way to Dharavi side and GRID LOCKS on both ends of the bridge!
@MTPHereToHelp @mybmcInfra
Sudhanwa Pathak MBBS retweeted
1. There is really no justification for it. The huge margins offered by drug manufacturers are due to market distortion. Manufacturers view the purchasers and prescribers, ie hospital and doctor, as their clients, not the patient on whom the medicine is used.
2. Controlling the margins on these drugs won’t affect research as claimed by manufacturers, since they are still free to fix their sale price to distributors. Only the subsequent exorbitant margin gets capped. However, corporate hospitals will certainly take a big hit and by and large their overall profit margins are not good enough to fully absorb this impact.
3. Bed charges, even in highest category of rooms, are well below the infra and running cost per bed of the hospital. It is a fact that hospitals cover the cost of stay and treatment primarily from high margins on pharmacy.
4. If margins from pharmacy and consumables too are cut off, you may find that hospitals substantially increase other charges to offset this substantial loss of income. We have seen this happen in coronary angioplasty - when margins on stents was capped, the procedure charges were increased to keep package cost the same.
5. Unfortunately in India, as of now services are not valued as much as products. Most patients are willing to pay 1 lakh for an implant, stent or medicine a lot more readily than giving the treating doctor 50k for his expertise. Additionally in oncology, the fear of cancer is a big incentive for people to spend any amount for medicines in the hope of cure. It is a sad reality that manufacturers, hospitals and doctors do exploit this situation. It is not a grand conspiracy, each of them is in it for their own reasons.
6. Even though I’m not a fan of overarching govt controls, in some situations such as this, the govt does need to step in and correct market distortions. I reiterate that for antibiotics too, rampant misuse due to high margins is causing scarily high rates of antibiotic resistance. The margins on all antibiotics must be made so low that there should be no incentive at all for misuse.
7. My opinion is that it is better for medical professionals to charge directly for services rendered, than rely on such indirect and somewhat unsavoury sources of income. People too should also get used to paying their treating doctors well for good, clean and timely services and treatment.
🚨 SUPREME COURT | “Can you show any justification for this loot?”
A cancer patient’s husband, a medical distributor, told the Supreme Court that an injection available to him at a dealer price of ₹11,000 was allegedly priced at ₹1.30 lakh by a reputed hospital, which refused to administer the injection he offered.
“Why this difference? Where does the money go?” Justice Sandeep Mehta asks the Centre.
Sudhanwa Pathak MBBS retweeted
Big news for Tuberculosis treatment: Indian Patent office refuses to grant patent for BPal treatment, a short regimen using Bedaquiline, pretomanid and linezolid. This will make the regimen affordable for many drug resistant TB patients @scroll_in
